Welcome to PharOS
Developing Value
Supplying Success
PharOS is a privately owned pharmaceutical company, developing and supplying generics and value added products with a global portfolio of more than 59 products and over 5.945 marketing authorizations worldwide.
READ MORE
1 3
Expertise
First to market
Last to Exit
PharOS is a multi-disciplinary organization, in recognition of the numerous different knowledge sets that are required for a proper pharmaceutical product development, registration and supply. Our expertise covers all aspects of product development from API sourcing up to market release.
READ MORE
2 3
The team
Our core competitive
advantage
At PharOS, we have a highly skilled workforce of more than 74 professionals all focused on developing and placing in the market top quality generic and other value added pharmaceuticals that improve the lives of patients to more than 65 countries.
READ MORE
3 3
29
PRODUCTS
LAUNCHED/DEVELOPED
30
PRODUCTS UNDER DEVELOPMENT /
UNDER REGISTRATION
60
Marketing Authorizations
Worldwide
84
COUNTRY
PRESENCE
OUR MISSION
FIRST TO LAUNCH, LAST TO EXIT
Our mission in PharOS is to materialize in the most efficient way our customers’ trust, by ensuring that their products will be among the first to be launched after patent expiry and the last ones to exit the market.
ABOUT PHAROS
TIMELINE
VIEW OUR STORY
FORCES UNITED
THE TEAM
OUR
WORLDWIDE
PRESENCE
MORE THAN 84 COUNTRIES
5945 MARKETING AUTHORIZATIONS
MORE THAN 350 CLIENTS
image/svg+xml
Presence
PRODUCTS
Today’s ideas...Tomorrow’s opportunities...
We provide affordable, high-quality medicines to more than 80 countries worldwide
VIEW ALL PRODUCTS
OUR EXPERTS...
our COMPETITIVE
ADVANTAGE
VIEW OUR EXPERTISE
LATEST NEWS
Today’s ideas...Tomorrow’s opportunities...
Our mission in PharOS is to materialize in the most efficient way our customers trust, by ensuring that their products will be among the first to be launched after patent expiry and the last ones to exit the market.
September, 18th 2017

17th Regulatory and Scientific Affairs Conference

17th Regulatory and Scientific Affairs Conference THE LANDMARK LONDON HOTEL, LONDON 25-26 January 2018
READ MORE
March, 28th 2017

PharOS interview at PharmaBoardRoom

The management team of PharOS discuss with PharmaBoardRoom the company’s move from generics consultancy to co-developer, surviving in the Greek market, and internationalization plans.
READ MORE
March, 3rd 2017

European and US regulators agree on mutual recognition of inspections of medicines manufacturers

Regulators in the European Union (EU) and the United States (US) have agreed to recognise inspections of manufacturing sites for human medicines conducted in their respective territories on both sides of the Atlantic.
READ MORE
October, 18th 2016

Another successful CPhI Worldwide
(Barcelona 2016)!

“It has been another exciting and successful participation at CPhI Worldwide in Barcelona. We would like to thank all of you that spend some time visiting PharOS's booth and looking forward seeing you next year in Frankfurt!”
READ MORE
VIEW ALL NEWS